Please assess the completion status of the following clinical trial:

Trial Title: Protect II, A Prospective, Multicenter Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Informed consent~* Subject is indicated for a NON emergent percutaneous treatment of at least on de novo or restenotic lesion in a native coronary vessel or bypass graft.~* Patient presents with:~  * A compromised Ejection Fraction~ * Intervention on the last patent coronary conduit~ * Intervention on an unprotected left main artery or~ * Patient presenting with triple vessel disease.~Exclusion Criteria:~* ST elevation M.I.~* Pre procedure cardiac arrest within 24 hours.~* Subject in cardiogenic shock

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- IMPELLA LP 2.5 (Type: EXPERIMENTAL): None
- IABP Intra-aortic balloon pump (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).